CASR and squamous cell lung carcinoma: Hypercalcemia in patients with advanced and/or metastatic disease has been reported to be strongly associated with poor prognosis [48] while inactivating mutations of the CaSR in exon 7 promoted the development of hypercalcemia in a xenograft mouse model of human squamous cell lung carcinoma [16].